The abstract is read at the publisher; the summary is JClub's.
Patients who prefer a language other than English are underrepresented in clinical research trials, and key barriers include missing translation/interpretation services and limited staff training.
- Why it matters: The literature does not clearly explain why language-based exclusion happens or how to address it ethically, especially in relation to Belmont Report principles.
- What they did: The work reviews ethical implications of excluding patients based on language preference and proposes practical strategies, including policy incentives, sponsor-funded translation/interpretation requirements, and augmented staff training.
- The result: The proposed approaches aim to enable language-concordant, culturally appropriate informed consent, improving meaningful access and benefit from oncology clinical research for patients who prefer a LOE.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.